OOIR: Observatory of International Research

Papers

(The H4-Index of Trends in Pharmacological Sciences is 47. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
More than one route to render tumors resistant to cGAS/STING activation	613
Subscription and Copyright Information	397
Subscription and Copyright Information	236
Subscription and Copyright Information	178
Therapeutic potential of cannabidiol polypharmacology in neuropsychiatric disorders	165
Subscription and Copyright Information	153
The N terminus-only function of adhesion GPCRs: emerging concepts	151
IRAK4: potential therapeutic target for airway disease exacerbations	146
Anticancer drugs: How to select small molecule combinations?	135
Subscription and Copyright Information	132
Subscription and Copyright Information	129
Advisory Board and Contents	128
Subscription and Copyright Information	124
Epitope landscape in autoimmune neurological disease and beyond	112
Advisory Board and Contents	104
Atogepant (Qulipta®) for migraine prevention	100
Promoting spliceosome assembly for therapeutic intent	97
Advisory Board and Contents	88
Advisory Board and Contents	86
Paving the way for designing drugs targeting TMEM16A	85
Subscription and Copyright Information	84
Subscription and Copyright Information	76
Advisory Board and Contents	76
Subscription and Copyright Information	75
Subscription and Copyright Information	72

Pharmacokinetic considerations to optimize clinical outcomes for COVID-19 drugs	70
Subscription and Copyright Information	69
Advisory Board and Contents	63
Lenacapavir (Sunlenca®) for the treatment of HIV-1	62
The consequences of particle uptake on immune cells	60
Boosting CAR-T cell therapy through vaccine synergy	58
Subscription and Copyright Information	58
Futibatinib (Lytgobi) for cholangiocarcinoma	57
Key metrics to expanding the pipeline of successful antibody–drug conjugates	57
Biochemical perspectives on targeting KMT2 methyltransferases in cancer	57
Obesity pharmacotherapy: incretin action in the central nervous system	56
Targeting of Potassium Channels in Cardiac Arrhythmias	54
Harnessing associative learning paradigms to optimize drug treatment	54
Channeling Force in the Brain: Mechanosensitive Ion Channels Choreograph Mechanics and Malignancies	54
Oteseconazole (VIVOJA) for prevention of recurrent vulvovaginal candidiasis	53
Shearing of surface mucin saps tumor cell strength	53
Intra- and intercellular signaling pathways associated with drug-induced cardiac pathophysiology	51
A novel anticancer pharmacological agent targeting mitochondrial complex I	50
Tackling chronic kidney disease in diabetic patients with finerenone	50
Biologics and cardiac disease: challenges and opportunities	49
Translational adaptation in breast cancer metastasis and emerging therapeutic opportunities	48
RH5 antigenic landscape shapes vaccine and antibody development	47
Leveraging macrophage metabolism for anticancer therapy: opportunities and pitfalls	47
Calcitonin/PAC1 receptor splice variants: a blind spot in migraine research	47
Structural asymmetry in FGF23 signaling	47